ABBY MCKINLEY: Open Payments
NPI 1518566512 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 19 payments from 12 companies in 2025. Trend: 2023 $568 · 2024 $561 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $189 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Novo Nordisk Inc | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Amgen Inc. | 1 | $20 |
| PFIZER INC. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: Kerendia, GEMTESA, FANAPT, PROQUAD, Ozempic, XIFAXAN, OTEZLA, NURTEC ODT.
Industry payments across KS — which companies pay providers there.
